MeVis Medical Solutions AG (DE:M3V)
XETRA:M3V
Holding DE:M3V?
Track your performance easily

MeVis Medical Solutions (M3V) Income Statement

2 Followers

MeVis Medical Solutions Income Statement

Last quarter (Q4 2022), MeVis Medical Solutions's total revenue was €―, a decrease of ― from the same quarter last year. In Q4, MeVis Medical Solutions's net income was €―. See MeVis Medical Solutions’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Sep 22Sep 21Sep 20Sep 19Sep 18
Total Revenue
-€ 18.76M€ 16.21M€ 17.13M€ 18.07M€ 17.77M
Cost of Revenue
-€ 746.56K€ 436.85K€ 626.21K€ 457.01K€ 579.52K
Gross Profit
-€ 18.02M€ 15.78M€ 16.50M€ 17.62M€ 17.20M
Operating Expense
-€ 11.64M€ 10.75M€ 10.33M€ 10.47M€ 9.99M
Operating Income
-€ 6.37M€ 5.03M€ 6.17M€ 7.14M€ 7.21M
Net Non Operating Interest Income Expense
-€ 174.07K€ 150.97K€ 162.93K€ -9.79K€ 141.23K
Other Income Expense
------
Pretax Income
-€ 7.88M€ 4.63M€ 5.79M€ 8.16M€ 7.71M
Tax Provision
-€ 87.11K€ 85.00K€ 90.48K€ 85.00K€ 88.64K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
-€ 7.79M€ 4.55M€ 5.70M€ 8.07M€ 7.62M
Basic EPS
-€ 4.28€ 2.50€ 3.13€ 4.43€ 3.94
Diluted EPS
-€ 4.28€ 2.50€ 3.13€ 4.43€ 3.94
Basic Average Shares
-€ 1.82M€ 1.82M€ 1.82M€ 1.82M€ 1.82M
Diluted Average Shares
-€ 1.82M€ 1.82M€ 1.82M€ 1.82M€ 1.82M
Dividend Per Share
-€ 0.00€ 0.00€ 0.95€ 0.95€ 0.00
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
-€ 552.00K€ 461.00K€ 431.00K€ 429.00K€ 598.00K
Total Expenses
-€ 12.39M€ 11.19M€ 10.96M€ 10.93M€ 10.57M
Net Income From Continuing And Discontinued Operation
-€ 7.79M€ 4.55M€ 5.70M€ 8.07M€ 7.62M
Normalized Income
-€ 7.79M€ 5.14M€ 6.00M€ 8.07M€ 7.62M
Interest Expense
-€ 3.85K€ 10.82K€ 11.73K€ 9.84K€ 17.22K
EBIT
-€ 7.88M€ 4.64M€ 5.81M€ 8.17M€ 7.72M
EBITDA
-€ 7.97M€ 4.77M€ 5.97M€ 8.42M€ 8.05M
Currency in EUR

MeVis Medical Solutions Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis